Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children

An altered ceramide composition in patients with inflammatory bowel disease (IBD) has been reported recently. The aim of this study was to evaluate the concentrations of sphingolipids in the serum of treatment-naive children with newly diagnosed IBD and to determine the diagnostic value of the teste...

Full description

Bibliographic Details
Main Authors: Aleksandra Filimoniuk, Agnieszka Blachnio-Zabielska, Monika Imierska, Dariusz Marek Lebensztejn, Urszula Daniluk
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Biomolecules
Subjects:
sphingolipid
lactosylceramide
ceramide
Crohn’s disease
ulcerative colitis
inflammatory bowel disease
Online Access:https://www.mdpi.com/2218-273X/10/7/1083

Internet

https://www.mdpi.com/2218-273X/10/7/1083

Similar Items